Brainstorm Cell Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.81 |
Market Cap |
$90.72 M |
Shares Outstanding |
21.7 M |
Public Float |
18.03 M |
Address |
1325 Avenue of Americas New York New Jersey 10019 United States |
Employees | - |
Website | http://www.brainstorm-cell.com |
Updated | 07/08/2019 |
Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NJ. |